Markets:

Overview

News

Currencies

International

Treasuries

Simulations Plus, Inc. - Common Stock (NQ:SLP)

20.33 +0.07 (+0.35%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Simulations Plus, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements

January 22, 2025

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024

January 13, 2025

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Q1 Earnings Assessment ↗

January 07, 2025

Via Benzinga

What to Expect from Simulations Plus's Earnings ↗

October 22, 2024

Via Benzinga

Breaking Down Simulations Plus: 2 Analysts Share Their Views ↗

September 12, 2024

Via Benzinga

Forecasting The Future: 4 Analyst Projections For Simulations Plus ↗

July 29, 2024

Via Benzinga

Simulations Plus Reports First Quarter Fiscal 2025 Financial Results

January 07, 2025

From Simulations Plus, Inc.

Via Business Wire

Earnings Scheduled For January 7, 2025 ↗

January 07, 2025

Via Benzinga

Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date

December 17, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus to Participate in the BTIG Digital Health Forum

November 19, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

November 13, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus to Participate in the Stephens Annual Investment Conference

November 06, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations

October 30, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results

October 23, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date

October 09, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings

October 08, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

August 28, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions

August 23, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Releases DILIsym® X

August 01, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Releases ADMET Predictor® Version 12

July 30, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus to Participate in KeyBanc’s 25th Annual Technology Leadership Forum

July 25, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety

July 11, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Stock Drops 15% Despite EPS Beat

July 05, 2024

Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance.

Via MarketBeat

Topics Artificial Intelligence

Simulations Plus Posts Q3 Results, Joins First Foundation And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

July 03, 2024

Via Benzinga

SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q3 2024 ↗

July 02, 2024

SLP stock results show that Simulations Plus beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.

Via InvestorPlace

Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results

July 02, 2024

From Simulations Plus, Inc.

Via Business Wire

Nasdaq Closes At Record High Led By Microsoft And Apple: Fear & Greed Index In 'Neutral' Zone ↗

July 02, 2024

Market sentiment improved as Nasdaq gains record level. S&P 500 and Dow Jones also rose, while some sectors closed negatively. Fear & Greed Index at 48.1.

Via Benzinga

Topics Stocks

MSC Industrial Direct, Radius Recycling And 3 Stocks To Watch Heading Into Tuesday ↗

July 02, 2024

Via Benzinga

Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit

June 20, 2024

From Simulations Plus, Inc.

Via Business Wire

Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date

June 18, 2024

From Simulations Plus, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.